BamSEC and AlphaSense Join Forces
Learn More

Infinity Pharmaceuticals Inc.

Formerly OTC: INFIQ
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 8 pages By Signing This Agreement, You Will Be Giving Up Valuable Legal Rights. for This Reason, It Is Very Important That You Carefully Review and Understand the Agreement Before Signing It. the Deadline for Accepting This Agreement Is Forty-Five (45) Days From the Date of Receipt of This Document. if You Do Not Sign and Return This Document Within the Forty-Five (45) Day Period, This Offer of Severance Pay Will Expire. the Company Encourages You to Take Advantage of This Period of Time by Consulting With a Lawyer, or Other Trusted Advisor, Before Signing the Document. 1. Employment Status and Final Payments
12/34/56
EX-10.49
from 10-K 3 pages Material contract
12/34/56
EX-10.48
from 10-K 3 pages Material contract
12/34/56
EX-10.47
from 10-K 4 pages Material contract
12/34/56
EX-10.46
from 10-K 3 pages Material contract
12/34/56
EX-10.1
from 10-K 69 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to 2019 Equity Incentive Plan of Infinity Pharmaceuticals, Inc
12/34/56
EX-10.2
from 10-Q 3 pages Material contract
12/34/56
EX-10.1
from 10-Q 3 pages Material contract
12/34/56
EX-10.2
from 10-Q 5 pages Infinity Pharmaceuticals, Inc. Amendment No. 1 to Amended and Restated Capital on Demandtm Sales Agreement Sales Agreement
12/34/56
EX-10.35
from 10-K 10 pages Infinity Pharmaceuticals, Inc. 2013 Employee Stock Purchase Plan
12/34/56
EX-10.16
from 10-K 17 pages Novation and Amendment Agreement
12/34/56
EX-10.15
from 10-K 59 pages Funding Agreement
12/34/56
EX-10.4
from 10-Q 1 page Amendment No. 3 to 2013 Employee Stock Purchase Plan of Infinity Pharmaceuticals, Inc
12/34/56
EX-10.3
from 10-Q 5 pages Infinity Pharmaceuticals, Inc. Stock Option Agreement
12/34/56
EX-10.4
from 10-Q 45 pages Office Lease 1100 Massachusetts Avenue, Cambridge, Ma
12/34/56
EX-10.3
from 10-Q ~10 pages Protective Rights Agreement
12/34/56
EX-10.2
from 10-Q ~50 pages Purchase and Sale Agreement Dated as of March 5, 2019 Between Infinity Pharmaceuticals, Inc. and Healthcare Royalty Partners III, L.P
12/34/56
EX-10.1
from 10-Q ~5 pages Amendment No. 4 to Amended and Restated Development and License Agreement
12/34/56
EX-10.2
from 10-Q 1 page Amendment No. 1 to Infinity Pharmaceuticals, Inc. Executive Severance Benefits Plan
12/34/56